IN-VITRO ACTIVITIES OF QUINUPRISTIN-DALFOPRISTIN AND THE STREPTOGRAMIN RPR-106972 AGAINST MYCOPLASMA-PNEUMONIAE

Authors
IZUMIKAWA K HIRAKATA Y YAMAGUCHI T YOSHIDA R TANAKA H TAKEMURA H MAESAKI S TOMONO K KAKU M IZUMIKAWA KI KAMIHIRA S KOHNO S
Citation
K. Izumikawa et al., IN-VITRO ACTIVITIES OF QUINUPRISTIN-DALFOPRISTIN AND THE STREPTOGRAMIN RPR-106972 AGAINST MYCOPLASMA-PNEUMONIAE, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 698-699
Citations number
14
Categorie Soggetti
Pharmacology & Pharmacy",Microbiology
Journal title
Antimicrobial agents and chemotherapy → ACNP
ISSN journal
00664804
Volume
42
Issue
3
Year of publication
1998
Pages
698 - 699
Database
ISI
SICI code
0066-4804(1998)42:3<698:IAOQAT>2.0.ZU;2-L
Abstract
The in vitro activities of quinupristin-dalfopristin and streptogramin RPR 106972 were determined with 44 strains of Mycoplasma pneumoniae a nd compared to those of macrolides, minocycline, and quinolones. All i solates tested were highly susceptible to macrolides and to quinuprist in-dalfopristin (MIC at which 90% of the isolates are inhibited [MIC90 ], 0.0625 mu g/ml), followed by RPR 106972 (MIC90, 0.5 mu g/ml), quino lones, and minocycline.